Atlas Trials

Tissue Kallikrein Preventing the Restenosis After Stenting of Symptomatic MCA Atherosclerotic Stenosis

Clinical trial NCT01558245 · UNKNOWN

Trial details

NCT number
NCT01558245
Sponsor
Jinling Hospital, China
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Cerebrovascular Disease
Start date
2011-12-01
Primary completion
2013-12-01
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.